why is b6 added to tirzepatide Compounded With (Pyridoxine) The Role of Vitamin B6

Adverse events such as diarrhea, constipation, nausea, and vomiting associated with the GLP-1 RAs overlap with those seen with cancer treatments, so the patient who is undergoing treatment with an emetogenic regimen for cancer will likely experience additional weight loss, which can lead to nutritional deficiencies, loss of lean muscle mass, and loss of bone mass

Smith, Phase II Metabolism, UNC Chapel Hill, 49 8/2012

Memory is unreliable, and guessing when you opened a vial is a recipe for using degraded medication

Regarding pancreatitis, other data have argued that, Switching between GLP-1 agonists may increase the risk of adverse effects, especially if dose titration protocols are not followed. Noteworthy: Other studies have found that semaglutide and tirzepatide may actually decrease the risk of recurrent acute pancreatitis. Above all, if you suspect you may be developing pancreatitis, consult with your doctor right away, who will likely advise you to stop taking the medication